Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats

被引:64
|
作者
Sueyoshi, Miyu [1 ]
Fukunaga, Masaki [1 ]
Mei, Mizue [1 ]
Nakajima, Atsushi [2 ]
Tanaka, Gaku [2 ]
Murase, Takayo [2 ]
Narita, Yuki [1 ,3 ]
Hirata, Sumio [1 ,3 ]
Kadowaki, Daisuke [1 ,3 ,4 ]
机构
[1] Kumamoto Univ, Fac Pharmaceut Sci, Dept Clin Pharmacol, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan
[2] Sanwa Kagaku Kenkyusho Co Ltd, Pharmaceut Res Labs, Inabe City, Mie, Japan
[3] Kumamoto Univ, Fac Pharmaceut Sci, Ctr Clin Pharmaceut Sci, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan
[4] Sojo Univ, Fac Pharmaceut Sci, Dept Clin Pharmaceut, Nishi Ku, 4-22-1 Ikeda, Kumamoto 8600082, Japan
关键词
Lactulose; Renal function; CKD; Uremic toxin; Gut microbiota; ORGANIC ANION TRANSPORTERS; P-CRESYL SULFATE; UREMIC TOXINS; OXIDATIVE STRESS; CONSTIPATION; THERAPIES; SOLUTE; ACIDS;
D O I
10.1007/s10157-019-01727-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
BackgroundConstipation is frequently observed in patients with chronic kidney disease (CKD). Lactulose is expected to improve the intestinal environment by stimulating bowel movements as a disaccharide laxative and prebiotic. We studied the effect of lactulose on renal function in adenine-induced CKD rats and monitored uremic toxins and gut microbiota.MethodsWistar/ST male rats (10-week-old) were fed 0.75% adenine-containing diet for 3weeks to induce CKD. Then, they were divided into three groups and fed as follows: control, normal diet; and 3.0- and 7.5-Lac, 3.0% and 7.5% lactulose-containing diets, respectively, for 4weeks. Normal diet group was fed normal diet for 7weeks. The rats were observed for parameters including renal function, uremic toxins, and gut microbiota.ResultsThe control group showed significantly higher serum creatinine (sCr) and blood urea nitrogen (BUN) 3weeks after adenine feeding than at baseline, with a 8.5-fold increase in serum indoxyl sulfate (IS). After switching to 4weeks of normal diet following adenine feeding, the sCr and BUN in control group remained high with a further increase in serum IS. In addition, tubulointerstitial fibrosis area was increased in control group. On the other hand, 3.0- and 7.5-Lac groups improved sCr and BUN levels, and suppressed tubulointerstitial fibrosis, suggesting preventing of CKD progression by lactulose. Lac groups also lowered level of serum IS and proportions of gut microbiota producing IS precursor.ConclusionLactulose modifies gut microbiota and ameliorates CKD progression by suppressing uremic toxin production.
引用
收藏
页码:908 / 919
页数:12
相关论文
共 50 条
  • [31] The Effects of Sacran, a Sulfated Polysaccharide, on Gut Microbiota Using Chronic Kidney Disease Model Rats
    Goto, Miwa
    Kobira, Yusei
    Kaneko, Shinichiro
    Arima, Hidetoshi
    Michihara, Akihiro
    Azuma, Kazuo
    Higashi, Taishi
    Motoyama, Keiichi
    Watanabe, Hiroshi
    Maruyama, Toru
    Kadowaki, Daisuke
    Otagiri, Masaki
    Iohara, Daisuke
    Hirayama, Fumitoshi
    Anraku, Makoto
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (05) : 576 - 582
  • [32] Chronic treatment of curcumin improves hepatic lipid metabolism and alleviates the renal damage in adenine-induced chronic kidney disease in Sprague-Dawley rats
    Ghelani, Hardik
    Razmovski-Naumovski, Valentina
    Chang, Dennis
    Nammi, Srinivas
    BMC NEPHROLOGY, 2019, 20 (01)
  • [33] Vascular, valvular and kidney calcification manifested in mouse models of adenine-induced chronic kidney disease
    Yang, Xin
    Liu, Yuqiu
    Zhu, Xiaodong
    Chen, Pingsheng
    Xie, Xiaotong
    Xu, Tian
    Zhang, Xiaoliang
    Zhao, Yu
    RENAL FAILURE, 2023, 45 (01)
  • [34] Effect of Acacia gum on blood pressure in rats with adenine-induced chronic renal failure
    Ali, Badreldin H.
    Ziada, Amal
    Al Husseni, Isehaq
    Beegam, Sumyia
    Al-Ruqaishi, Bader
    Nemmar, Abderrahim
    PHYTOMEDICINE, 2011, 18 (13) : 1176 - 1180
  • [35] Adenine-induced animal model of chronic kidney disease: current applications and future perspectives
    Yang, Qiao
    Su, Songya
    Luo, Nan
    Cao, Gang
    RENAL FAILURE, 2024, 46 (01)
  • [36] Dietary phosphate restriction ameliorates endothelial dysfunction in adenine-induced kidney disease rats
    Tan Vu Van
    Watari, Eriko
    Taketani, Yutaka
    Kitamura, Tomoyo
    Shiota, Asuka
    Tanaka, Terumi
    Tanimura, Ayako
    Harada, Nagakatsu
    Nakaya, Yutaka
    Yamamoto, Hironori
    Miyamoto, Ken-ichi
    Takeda, Eiji
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2012, 51 (01) : 27 - 32
  • [37] Clinical Perspectives of Gut Microbiota in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: Where Do We Stand?
    Pantazi, Alexandru Cosmin
    Kassim, Mustafa Ali Kassim
    Nori, Wassan
    Tuta, Liliana Ana
    Mihai, Cristina Maria
    Chisnoiu, Tatiana
    Balasa, Adriana Luminita
    Mihai, Larisia
    Lupu, Ancuta
    Frecus, Corina Elena
    Lupu, Vasile Valeriu
    Chirila, Sergiu Ioachim
    Badescu, Anca Gabriela
    Hangan, Laurentiu-Tony
    Cambrea, Simona Claudia
    BIOMEDICINES, 2023, 11 (09)
  • [38] Causal effects of gut microbiota on the risk of chronic kidney disease: a Mendelian randomization study
    Luo, Mingli
    Cai, Jiahao
    Luo, Shulu
    Hong, Xiaosi
    Xu, Lingxin
    Lin, Honghong
    Chen, Xiong
    Fu, Wen
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [39] Dose-dependent therapeutic effects of gum acacia on kidney and metabolic dysfunction in adenine-induced chronic kidney disease in rats: involvement of antioxidant pathways
    Hadeer Badry
    Nadia M. El-Beih
    Aya M. Hussein
    Hanaa F. Abd El-Kareem
    Wael M. El-Sayed
    The Journal of Basic and Applied Zoology, 86 (1)
  • [40] Infliximab abrogates adenine-induced chronic kidney disease via modulation of the MAPK/JNK/ASK signaling pathway in rats
    Nageeb, Mahitab M.
    Talaat, Aliaa
    Reda, Samar M.
    Elsammak, Ghada A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (01) : 207 - 219